0001525594-13-000005.txt : 20131224 0001525594-13-000005.hdr.sgml : 20131224 20131224123735 ACCESSION NUMBER: 0001525594-13-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131224 DATE AS OF CHANGE: 20131224 EFFECTIVENESS DATE: 20131224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Variation Biotechnologies (US), Inc. CENTRAL INDEX KEY: 0001525594 IRS NUMBER: 980526196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-208713 FILM NUMBER: 131297064 BUSINESS ADDRESS: STREET 1: 222 3RD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (617) 830-3031 MAIL ADDRESS: STREET 1: 222 3RD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D 1 primary_doc.xml X0707 D LIVE 0001525594 Variation Biotechnologies (US), Inc. 222 3RD STREET SUITE 2241 CAMBRIDGE MA MASSACHUSETTS 02141 (617) 830-3031 DELAWARE None None Corporation true Jeff Baxter 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Egidio Nascimento 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Executive Officer Michael Steinmetz 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Director Stephen Gillis 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Director Kevin Forrest 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Director Marc J. Kirchmeier 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Executive Officer David E. Anderson 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Executive Officer Adam Buckley 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Executive Officer Steve Vignau 222 3rd Street Suite 2241 Cambridge MA MASSACHUSETTS 02141 Director Biotechnology Decline to Disclose 06b false 2013-09-30 false true false 0 1375000 1375000 0 Date of sale for one tranche of Notes totaling $750,000 was 09/30/2013. Date of sale of other tranche of Notes totaling $625,000 was 12/11/2013 false 2 0 0 0 false Variation Biotechnologies (US), Inc. /s/ Jeff Baxter Jeff Baxter President & CEO 2013-12-23